メディシノバ・インクの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/05/09 | 1,186 | 1,187 | 1,116 | 1,136 | -56 | -4.7% | 482,900 |
2018/05/08 | 1,200 | 1,206 | 1,187 | 1,192 | +2 | +0.2% | 102,800 |
2018/05/07 | 1,199 | 1,200 | 1,181 | 1,190 | -15 | -1.2% | 142,700 |
2018/05/02 | 1,190 | 1,210 | 1,190 | 1,205 | +7 | +0.6% | 92,900 |
2018/05/01 | 1,206 | 1,210 | 1,180 | 1,198 | -50 | -4% | 291,900 |
2018/04/27 | 1,220 | 1,249 | 1,196 | 1,248 | +28 | +2.3% | 249,100 |
2018/04/26 | 1,281 | 1,281 | 1,219 | 1,220 | +7 | +0.6% | 230,100 |
2018/04/25 | 1,165 | 1,242 | 1,151 | 1,213 | +23 | +1.9% | 337,300 |
2018/04/24 | 1,219 | 1,226 | 1,180 | 1,190 | -67 | -5.3% | 675,900 |
2018/04/23 | 1,247 | 1,281 | 1,240 | 1,257 | -42 | -3.2% | 183,000 |
2018/04/20 | 1,210 | 1,302 | 1,206 | 1,299 | +60 | +4.8% | 255,200 |
2018/04/19 | 1,280 | 1,280 | 1,233 | 1,239 | -44 | -3.4% | 217,400 |
2018/04/18 | 1,308 | 1,318 | 1,282 | 1,283 | -2 | -0.2% | 172,000 |
2018/04/17 | 1,250 | 1,295 | 1,201 | 1,285 | -23 | -1.8% | 798,100 |
2018/04/16 | 1,375 | 1,375 | 1,300 | 1,308 | -82 | -5.9% | 446,300 |
2018/04/13 | 1,385 | 1,391 | 1,361 | 1,390 | +30 | +2.2% | 305,100 |
2018/04/12 | 1,331 | 1,371 | 1,331 | 1,360 | +7 | +0.5% | 246,600 |
2018/04/11 | 1,370 | 1,395 | 1,334 | 1,353 | +35 | +2.7% | 439,700 |
2018/04/10 | 1,350 | 1,369 | 1,316 | 1,318 | -14 | -1.1% | 250,800 |
2018/04/09 | 1,330 | 1,350 | 1,285 | 1,332 | -29 | -2.1% | 540,300 |
2018/04/06 | 1,375 | 1,379 | 1,348 | 1,361 | -27 | -1.9% | 499,500 |
2018/04/05 | 1,388 | 1,405 | 1,370 | 1,388 | +13 | +0.9% | 443,700 |
2018/04/04 | 1,399 | 1,414 | 1,364 | 1,375 | +6 | +0.4% | 703,500 |
2018/04/03 | 1,330 | 1,414 | 1,302 | 1,369 | +17 | +1.3% | 1,097,200 |
2018/04/02 | 1,400 | 1,477 | 1,352 | 1,352 | +112 | +9% | 2,021,200 |
2018/03/30 | 1,130 | 1,278 | 1,116 | 1,240 | -110 | -8.1% | 1,468,400 |
2018/03/29 | 1,298 | 1,397 | 1,280 | 1,350 | +82 | +6.5% | 443,300 |
2018/03/28 | 1,235 | 1,282 | 1,230 | 1,268 | -24 | -1.9% | 312,900 |
2018/03/27 | 1,320 | 1,335 | 1,281 | 1,292 | +2 | +0.2% | 258,300 |
2018/03/26 | 1,218 | 1,296 | 1,126 | 1,290 | +45 | +3.6% | 547,700 |
2018/03/23 | 1,223 | 1,275 | 1,221 | 1,245 | -40 | -3.1% | 475,900 |
2018/03/22 | 1,301 | 1,330 | 1,277 | 1,285 | -48 | -3.6% | 490,700 |
2018/03/20 | 1,298 | 1,372 | 1,296 | 1,333 | -40 | -2.9% | 360,100 |
2018/03/19 | 1,441 | 1,447 | 1,271 | 1,373 | -90 | -6.2% | 654,300 |
2018/03/16 | 1,482 | 1,485 | 1,445 | 1,463 | -7 | -0.5% | 238,500 |
2018/03/15 | 1,458 | 1,488 | 1,423 | 1,470 | -20 | -1.3% | 488,000 |
2018/03/14 | 1,470 | 1,496 | 1,441 | 1,490 | +44 | +3% | 679,700 |
2018/03/13 | 1,380 | 1,448 | 1,368 | 1,446 | +91 | +6.7% | 696,100 |
2018/03/12 | 1,347 | 1,381 | 1,330 | 1,355 | +38 | +2.9% | 462,700 |
2018/03/09 | 1,340 | 1,372 | 1,311 | 1,317 | -47 | -3.4% | 636,800 |
2018/03/08 | 1,315 | 1,384 | 1,301 | 1,364 | +60 | +4.6% | 763,300 |
2018/03/07 | 1,230 | 1,320 | 1,217 | 1,304 | +88 | +7.2% | 1,111,000 |
2018/03/06 | 1,185 | 1,219 | 1,169 | 1,216 | +72 | +6.3% | 413,700 |
2018/03/05 | 1,200 | 1,220 | 1,131 | 1,144 | -36 | -3.1% | 581,800 |
2018/03/02 | 1,140 | 1,190 | 1,137 | 1,180 | +22 | +1.9% | 397,500 |
2018/03/01 | 1,130 | 1,190 | 1,126 | 1,158 | +13 | +1.1% | 285,500 |
2018/02/28 | 1,125 | 1,166 | 1,125 | 1,145 | -22 | -1.9% | 235,800 |
2018/02/27 | 1,175 | 1,190 | 1,143 | 1,167 | +3 | +0.3% | 233,700 |
2018/02/26 | 1,190 | 1,206 | 1,156 | 1,164 | +14 | +1.2% | 339,800 |
2018/02/23 | 1,130 | 1,167 | 1,107 | 1,150 | +11 | +1% | 342,100 |
1751~
1800
件表示中 / 3737件
類似銘柄と比較する
現在ご覧いただいている「メディシノバ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
メディシノバ | 18,500円 | - | - | - | - | - |
|
- |
ソレイジア | 4,400円 | +311.4% | - | 0.00% | - | 8.45倍 |
|
がん柱の創薬ベンチャー。候補品導入後に開発進め権利再導出、製品販売を行うビジネスモデル |
NANO | 13,800円 | -30.6% | - | 0.00% | - | 3.58倍 |
|
mRNA医薬品に特化した創薬ベンチャー。創薬シーズ発掘から臨床開発まで手がけて導出 |
仁 丹 | 212,100円 | +0.3% | +9.2% | 3.06% | 12.05倍 | 0.71倍 |
|
代名詞の仁丹から整腸作用軸に健康サプリ、医薬品へ展開。シームレスカプセル技術に特長 |
シンバイオ | 17,100円 | -42.9% | - | 0.00% | - | 2.15倍 |
|
導入で新薬開発・製品化。抗がん剤「トレアキシン」国内販売。抗ウイルス薬BCVの開発に注力 |
市場注目の銘柄
チャート関連のコラム